Preparation of a Eurogrant project planned for implementation within the framework of the HORIZON programme for the comprehensive control of chronic obesity."The premise of the project is to comprehensively support the control of chronic obesity and the resulting life-threatening disorders in women and men aged 35-60 years in the Pomeranian Voivodeship in the years 2022-2032 using state-of-the-art Hi-tech medical technologies with efficacy confirmed by clinical studies The analysis of the research conducted will take into account factors such as the urban/rural dichotomy, socio-economic status, age groups, gender differences, as well as food and environmental issues.

Project objective
Submission of Horizon application in July 2022 call Prevention of obesity throughout the life course. The grant will fund activities that will contribute to maintaining health in a rapidly changing society. The proposal will involve improving health parameters in obese patients with a BMI greater than 30 between the ages of 35 and 60. The project will include activities to minimise the effects of acquired metabolic disorders, i.e. hyperglycaemia, insulin resistance, hypertension, hypercholesterolaemia, hypertriglyceridaemia.
The aim is to demonstrate on a control group that

1. Wellclinic's weight-loss therapy has a direct effect on improving the health parameters of previously studied subjects.
2.Fat loss improves wellbeing, self-esteem and mental health parameters in patients receiving therapy.
3. the effect of the therapy - the improvement in health parameters is long-lasting.

Beneficiary Wellclinic Limited Liability Company